PANTHER THERAPEUTICS
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
PANTHER THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.panthertx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
21.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google GStatic Google Static Content Google Cloud COVID-19
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
TargetGene Biotechnologies
Therapeutic Gene Editing
Current Advisors List
Current Employees Featured
Founder
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - PanTher Therapeutics
Angel Physicians Fund
Angel Physicians Fund investment in Series A - PanTher Therapeutics
Catalyst Health Ventures
Catalyst Health Ventures investment in Series A - PanTher Therapeutics
Craig Bloem
Craig Bloem investment in Series A - PanTher Therapeutics
Kli Capital
Kli Capital investment in Convertible Note - PanTher Therapeutics
Official Site Inspections
http://www.panthertx.com
- Host name: 30.77.196.35.bc.googleusercontent.com
- IP address: 35.196.77.30
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "PanTher Therapeutics"
About Us - panthertx.com
ABOUT Our mission is to redefine cancer treatment with therapeutics administered exclusively at the tumor site to transform clinical outcomes and minimize side effects.See details»
PanTher Therapeutics - Crunchbase Company Profile
PanTher Therapeutics features treatment platform designed to enhance therapeutic response with minimal side effects.See details»
PanTher Therapeutics
Aug 13, 2024 PanTher’s technology unleashes the inherent power of cancer-fighting drugs by enabling continuous, high-dose treatment exclusively at the site of a tumor.See details»
Team Members - panthertx.com
Dan Wildman, in addition to being a Board member, is a Strategic Advisor to PanTher Therapeutics. In this role Dan applies his expertise and decades of experience to advancing …See details»
PanTher Therapeutics Company Profile | Management and
Find contact information for PanTher Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and PanTher Therapeutics's email format.See details»
Overview, News & Similar companies - ZoomInfo.com
Apr 5, 2024 View PanTher Therapeutics (www.panthertx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
PanTher Therapeutics, Inc. - Drug pipelines, Patents, …
Mar 8, 2025 For more information, visit www.panthertx.com . About PTM-101 PanTher’s lead clinical product, PTM-101, is a proprietary flexible absorbable film that enables continuous, high-dose administration of paclitaxel directly to the …See details»
PanTher Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore PanTher Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news, Disease Domain:Neoplasms, Endocrinology ...See details»
PanTher Therapeutics Announces Appointment of John Edwards …
Apr 5, 2024 PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company developing high-dose, long lasting, localized treatments for cancer, announced that …See details»
PanTher Therapeutics Presents Positive First-in-Human …
AUSTIN, Texas, April 08, 2024--PanTher Therapeutics ("PanTher" or the "Company"), a clinical-stage oncology company developing high-dose, long lasting, localized treatments for cancer, today ...See details»
News - panthertx.com
Apr 8, 2024 PanTher Therapeutics Presents Positive First-in-Human Data for PTM-101 in Pancreatic Cancer at AACR Annual MeetingSee details»
PanTher Therapeutics Receives Ethics Approval to Initiate Phase 1 ...
Aug 4, 2021 PanTher Therapeutics (PanTher), a privately held oncology company revolutionizing the treatment of solid tumors with its proprietary treatment platform designed …See details»
PanTher Therapeutics Announces Appointment of John Edwards
Apr 5, 2024 “John has successfully guided many biotech companies through key stages in their evolution and he is a tremendous resource for our organization.” John brings over 35 years of …See details»
PANTHERx Company Profile - Office Locations, Competitors ... - Craft
PANTHERx has 5 employees across 3 locations and $1.18 b in annual revenue in Y 2019. See insights on PANTHERx including office locations, competitors, revenue, financials, executives, …See details»
Our Technology - panthertx.com
Leveraging decades of material science, pharmacology, and cancer biology, PanTher’s technology has emerged as the solution many have been looking for in order to continuously …See details»
PanTher Therapeutics Closes Oversubscribed $5.4M Series A …
Jun 17, 2021 PanTher Therapeutics (PanTher), a privately held oncology company revolutionizing the treatment of solid tumors through direct, localized, and sustained delivery of …See details»
PANTHERx’s New Website and Industry Defining Name
A Pure Rare Focus As the leader in the rare disorder and orphan drug industry, PANTHERx determined that the “Specialty” moniker no longer accurately conveyed its focus and niche …See details»
panthertx.net
Panthertx.netSee details»
Privacy Policy - panthertx.com
2.5.1 your name, gender, age, and date of birth; 2.5.2 your contact information, such as your address and contact details (including your email and mobile telephone number); 2.5.3 country …See details»
PowerPoint Presentation
Background Improvements in the treatment of pancreatic cancer have been very limited, in part due to the inability to deliver chemotherapy to the tumor at efficacious concentrations for …See details»